BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19016693)

  • 1. Psoriatic disease and tuberculosis nowadays.
    Balato N; Di Costanzo L; Ayala F; Balato A; Sanduzzi A; Bocchino M
    Clin Dev Immunol; 2012; 2012():747204. PubMed ID: 22645622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue
    Ha R; Keynan Y; Rueda ZV
    Front Cell Infect Microbiol; 2022; 12():980868. PubMed ID: 36159650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections in the era of immunobiologicals.
    Romiti R; Hirayama ALDS; Porro AM; Gonçalves HS; Miot LDB; Durães SMB; Marques SA
    An Bras Dermatol; 2024; 99(2):167-180. PubMed ID: 38238209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF inhibitors and cardiovascular risk: Friend or foe?
    Gelfand JM; Garshick M
    J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):995-996. PubMed ID: 38794923
    [No Abstract]   [Full Text] [Related]  

  • 5. Miliary tuberculosis and herpes pharyngitis after a trip to a developing country: dangers of biologics.
    Patel S; Weaver MD; Roy S
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of inflammatory rheumatic conditions in the elderly.
    Lahaye C; Tatar Z; Dubost JJ; Tournadre A; Soubrier M
    Rheumatology (Oxford); 2019 May; 58(5):748-764. PubMed ID: 29982766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal disseminated tuberculosis in patients under biological treatment - two clinical cases and a short review.
    Dantes E; Tofolean DE; Fildan AP; Craciun L; Dumea E; Tofolean IT; Mazilu L
    J Int Med Res; 2018 Jul; 46(7):2961-2969. PubMed ID: 29792084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.
    Ogata H; Watanabe M; Matsui T; Hase H; Okayasu M; Tsuchiya T; Shinmura Y; Hibi T
    J Crohns Colitis; 2016 Sep; 10(9):1033-41. PubMed ID: 26961546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.
    Li CR; Mao QX; Chen M; Jia WX; Yao X; Feng SY; Jia H; Gong JQ; Yang XY
    Drug Des Devel Ther; 2015; 9():5591-4. PubMed ID: 26508833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review.
    Solovan C; Chiticariu E
    Infect Dis Ther; 2013 Jun; 2(1):59-73. PubMed ID: 25135824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivation of Tuberculosis in Three Cases of Psoriasis after Initiation of Anti-TNF Therapy.
    Shaikha SA; Mansour K; Riad H
    Case Rep Dermatol; 2012 Jan; 4(1):41-6. PubMed ID: 22529801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There a Potential Role for Anti-tumor Necrosis Factor Therapy in Patients with Human Immunodeficiency Virus?
    Emer JJ
    J Clin Aesthet Dermatol; 2009 Apr; 2(4):29-35. PubMed ID: 20729936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
    Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
    J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious risk].
    Calabuig E; Salavert M
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella zoster virus infection in patients taking the TNF-alpha inhibitor, etanercept: coincidence or causal?
    Izumi A
    Hawaii Med J; 2009 Dec; 68(11):277-8. PubMed ID: 20034255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union.
    Smith MY; Attig B; McNamee L; Eagle T
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1168-73. PubMed ID: 22794309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
    Krueger G; Callis K
    Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.
    Perlmutter A; Mittal A; Menter A
    Br J Dermatol; 2009 Jan; 160(1):8-15. PubMed ID: 19016693
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.